Andrea S. James insider trades

Open-market stock purchases and sales by Andrea S. James, Chief Financial Officer at Insight Molecular Diagnostics Inc, from SEC Form 4 filings since Jun 20, 2024.

Recent trades

DateStockTradeValue
Mar 26, 2026IMDX Insight Molecular Diagnostics IncSold (not open market)$46.4K
Mar 26, 2026IMDX Insight Molecular Diagnostics IncBought (not open market)—
Oct 31, 2025IMDX Insight Molecular Diagnostics IncBought (not open market)—
Oct 31, 2025IMDX Insight Molecular Diagnostics IncSold (not open market)—
Oct 31, 2025IMDX Insight Molecular Diagnostics IncSold (not open market)$73.2K
Oct 31, 2025IMDX Insight Molecular Diagnostics IncBought (not open market)—

Companies traded

  • IMDX Insight Molecular Diagnostics Inc: other filings, last Mar 26, 2026
  • OCX Oncocyte Corp: 3 buys, last Mar 26, 2025

Get free alerts when Andrea S. James files a new trade →